IBDEI0BR ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5186,1,2,0)
 ;;=2^228.01
 ;;^UTILITY(U,$J,358.3,5186,1,5,0)
 ;;=5^Hemangioma Skin
 ;;^UTILITY(U,$J,358.3,5186,2)
 ;;=^267697
 ;;^UTILITY(U,$J,358.3,5187,0)
 ;;=705.83^^25^301^2
 ;;^UTILITY(U,$J,358.3,5187,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5187,1,2,0)
 ;;=2^705.83
 ;;^UTILITY(U,$J,358.3,5187,1,5,0)
 ;;=5^Hidradentitis Suppuritiva
 ;;^UTILITY(U,$J,358.3,5187,2)
 ;;=^184621
 ;;^UTILITY(U,$J,358.3,5188,0)
 ;;=704.1^^25^301^3
 ;;^UTILITY(U,$J,358.3,5188,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5188,1,2,0)
 ;;=2^704.1
 ;;^UTILITY(U,$J,358.3,5188,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,5188,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,5189,0)
 ;;=780.8^^25^301^7
 ;;^UTILITY(U,$J,358.3,5189,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5189,1,2,0)
 ;;=2^780.8
 ;;^UTILITY(U,$J,358.3,5189,1,5,0)
 ;;=5^Hyperhidrosis
 ;;^UTILITY(U,$J,358.3,5189,2)
 ;;=^60030
 ;;^UTILITY(U,$J,358.3,5190,0)
 ;;=709.09^^25^301^6
 ;;^UTILITY(U,$J,358.3,5190,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5190,1,2,0)
 ;;=2^709.09
 ;;^UTILITY(U,$J,358.3,5190,1,5,0)
 ;;=5^Hyper/hypopigmentation
 ;;^UTILITY(U,$J,358.3,5190,2)
 ;;=^303313
 ;;^UTILITY(U,$J,358.3,5191,0)
 ;;=079.4^^25^301^5
 ;;^UTILITY(U,$J,358.3,5191,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5191,1,2,0)
 ;;=2^079.4
 ;;^UTILITY(U,$J,358.3,5191,1,5,0)
 ;;=5^Human Papillomavirus
 ;;^UTILITY(U,$J,358.3,5191,2)
 ;;=^295791
 ;;^UTILITY(U,$J,358.3,5192,0)
 ;;=708.9^^25^301^4
 ;;^UTILITY(U,$J,358.3,5192,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5192,1,2,0)
 ;;=2^708.9
 ;;^UTILITY(U,$J,358.3,5192,1,5,0)
 ;;=5^Hives
 ;;^UTILITY(U,$J,358.3,5192,2)
 ;;=^124650
 ;;^UTILITY(U,$J,358.3,5193,0)
 ;;=695.89^^25^302^2
 ;;^UTILITY(U,$J,358.3,5193,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5193,1,2,0)
 ;;=2^695.89
 ;;^UTILITY(U,$J,358.3,5193,1,5,0)
 ;;=5^Intertrigo
 ;;^UTILITY(U,$J,358.3,5193,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,5194,0)
 ;;=684.^^25^302^1
 ;;^UTILITY(U,$J,358.3,5194,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5194,1,2,0)
 ;;=2^684.
 ;;^UTILITY(U,$J,358.3,5194,1,5,0)
 ;;=5^Impetigo
 ;;^UTILITY(U,$J,358.3,5194,2)
 ;;=^62068
 ;;^UTILITY(U,$J,358.3,5195,0)
 ;;=176.0^^25^303^1
 ;;^UTILITY(U,$J,358.3,5195,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5195,1,2,0)
 ;;=2^176.0
 ;;^UTILITY(U,$J,358.3,5195,1,5,0)
 ;;=5^Kaposi's Sarcoma
 ;;^UTILITY(U,$J,358.3,5195,2)
 ;;=^267206
 ;;^UTILITY(U,$J,358.3,5196,0)
 ;;=701.1^^25^303^2
 ;;^UTILITY(U,$J,358.3,5196,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5196,1,2,0)
 ;;=2^701.1
 ;;^UTILITY(U,$J,358.3,5196,1,5,0)
 ;;=5^Keratoderma
 ;;^UTILITY(U,$J,358.3,5196,2)
 ;;=^66809
 ;;^UTILITY(U,$J,358.3,5197,0)
 ;;=709.09^^25^304^3
 ;;^UTILITY(U,$J,358.3,5197,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5197,1,2,0)
 ;;=2^709.09
 ;;^UTILITY(U,$J,358.3,5197,1,5,0)
 ;;=5^Lentigo, Benign
 ;;^UTILITY(U,$J,358.3,5197,2)
 ;;=^303313
 ;;^UTILITY(U,$J,358.3,5198,0)
 ;;=272.6^^25^304^1
 ;;^UTILITY(U,$J,358.3,5198,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5198,1,2,0)
 ;;=2^272.6
 ;;^UTILITY(U,$J,358.3,5198,1,5,0)
 ;;=5^Lipodystrophy
 ;;^UTILITY(U,$J,358.3,5198,2)
 ;;=^71106
 ;;^UTILITY(U,$J,358.3,5199,0)
 ;;=214.9^^25^304^2
 ;;^UTILITY(U,$J,358.3,5199,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5199,1,2,0)
 ;;=2^214.9
 ;;^UTILITY(U,$J,358.3,5199,1,5,0)
 ;;=5^Lipoma
 ;;^UTILITY(U,$J,358.3,5199,2)
 ;;=^71155
 ;;^UTILITY(U,$J,358.3,5200,0)
 ;;=709.09^^25^305^1
 ;;^UTILITY(U,$J,358.3,5200,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5200,1,2,0)
 ;;=2^709.09
 ;;^UTILITY(U,$J,358.3,5200,1,5,0)
 ;;=5^Melasma
 ;;^UTILITY(U,$J,358.3,5200,2)
 ;;=^303313
 ;;
 ;;$END ROU IBDEI0BR
